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Abstract
I In nt tr ro od du uc ct ti io on n: :   The aim of this study was to investigate the association between
the variation in expression profile of clock genes and obesity using peripheral
blood mononuclear (PMN) cells.
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   The subjects comprised 10 obese patients and 10 healthy
volunteers. Blood was collected at different time-points during the day and lev-
els of blood sugar, IRI, adiponectin and leptin were determined. Peripheral blood
mononuclear cells were sampled, and expression levels of brain and muscle
Arnt-like protein-1 (BMAL1), Period (PER)1, PER2, Cryptochrome (CRY)1, CRY2,
and REV-ERBʱ mRNA were quantified.
R Re es su ul lt ts s: :   During the day, the expression levels of BMAL1, CRY1, CRY2 and PER2
genes in PMN cells of the obese group were all significantly higher compared
to those in the non-obese group. In addition, expression of BMAL1, CRY1, CRY2
and PER2 genes in PMN cells increased between 12:00 and 21:00 in the obese
group. In PMN cells of both groups, PER1 gene expression showed a bimodal
pattern, with high expression at 9:00 and 18:00.
C Co on nc cl lu us si io on ns s: :   Differences were observed in the expression profile variation of
clock genes between the obese and non-obese groups. This study reveals the
differences in clock gene expression profiles between obese and non-obese sub-
jects, with evidence for two distinct chronotypes, and suggests a contribution
of these chronotypes to fat accumulation in humans. 
K Ke ey y   w wo or rd ds s: :   circadian rhythm, biological clock, Per1, Bmal1.
Introduction
The circadian rhythm is the daily cycle of physiology and behaviour, driv-
en by an endogenous oscillator over the period of each day. This rhythm
is controlled by the circadian clock, subject to regulation by the light-dark
cycle [1-3]. In mammals, the circadian orchestration of these processes is
C Co or rr re es sp po on nd di in ng g   a au ut th ho or r: :   
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governed by pacemaker cells located within the
suprachiasmatic  nucleus  of  the  hypothalamus 
[4, 5]. Circadian oscillators have also been found to
exist not only in the suprachiasmatic nucleus, but
also in peripheral tissues [6-10].
Rhythmic transcriptional enhancement in periph-
eral tissues provides the basic drive to the system
though two transcription factors, circadian loco-
motor output cycles protein kaput (CLOCK), and
brain and muscle Arnt-like protein-1 (BMAL1) [11].
The CLOCK-BMAL1 heterodimer directly or indi-
rectly activates the transcription of various clock-
controlled genes. In parallel, the heterodimer also
activates the transcription of several clock genes,
including Period (Per)1, Per2 and Cryptochrome
(Cry)1, Cry2. PER and CRY proteins then translocate
back into the nucleus, and inhibit the activity of
CLOCK-BMAL1, forming a negative feedback loop
[12, 13]. These clock genes then control the circadi-
an rhythm by regulating the expression of multiple
clock-controlled genes [11]. 
Peripheral adipose tissues have previously been
thought to be responsible only for storage of excess
energy derived from the diet as fat. In addition to
this role, recent studies have revealed that adipose
tissue secretes a number of biologically active mol-
ecules called adipokines [14, 15]. The circulating lev-
el of one of these adipokines, leptin, exhibits a clear
daily variation in animals and humans [9, 16, 17].
Plasma leptin levels are lowest during light periods,
and peak during dark periods. Moreover, plasma
adiponectin concentrations in non-obese subjects
show a 24 h rhythmic cycle, which is absent in
obese subjects [18, 19]. In addition, altered expres-
sion of the clock genes has been reported in the liv-
ers of diabetic (db/db) mice [20].
Shimba et al. used 3T3-L1 adipocytes and BMAL1
knockout mice to demonstrate that induction of
BMAL1 gene expression occurs during adipocyte dif-
ferentiation. This suggests a contribution of BMAL1
to the regulation of adipocyte differentiation and
lipogenesis in mature adipocytes [21]. Understand-
ing of clock gene expression has remained limited
due to restricted access to the biological material
required for gene expression studies.
Rhythmic mRNA expression profiles for human
clock genes from oral mucosa and skin biopsies
indicate that a peripheral clock is also present in
humans [22]. An attractive alternative to tissue
biopsies for monitoring human circadian oscillator
activity is to use peripheral mononuclear blood cells,
in  which  expression  of  clock  genes  has  been
demonstrated to occur. Expression of circadian clock
related genes in peripheral blood cells varies dur-
ing the day [23]. In this study, the association
between daytime variation in genes related to cir-
cadian rhythm and obesity was investigated using
peripheral blood mononuclear cells.
Material and methods
S St tu ud dy y   d de es si ig gn n
This study has been approved by and carried out
according to the instructions of Nihon University
Ethics Committee. Twenty study participants were
used and informed consent was obtained. Only
male subjects were included to avoid a putative
interference between circadian rhythm and the
ovarian cycle. Inclusion criteria for the obese group
were a body mass index above 25 kg/m2, and
a waist circumference above 85 cm. For the non-
obese group a body mass index less than 25 kg/m2,
and a waist circumference of less than 85 cm were
required. Subjects who had experienced either jet
lag or shift work during the 2 weeks preceding the
experiment, or who had taken psychotropic drugs,
were excluded from the study. None of the subjects
had a history of stress or psychiatric disease, or
were taking medications. Each subject was asked
to follow a regular daily routine of wakefulness and
sleep before the experiment. Subjects ate break-
fast at 09:15, lunch at 12:15 and dinner at 18:15 just
after blood sampling. The collection of peripheral
blood was performed at 09:00, 12:00, 15:00, 18:00
and 21:00. All subjects followed the same menu for
their meals.
Serum leptin, adiponectin, insulin and high-sen-
sitivity C-reactive protein (hs-CRP) levels were deter-
mined at 09:00. Plasma lipid, glucose, melatonin,
and cortisol levels were determined at each time
point. Peripheral blood mononuclear cells were iso-
lated and their levels of BMAL1, PER1, PER2, CRY1,
CRY2, REV-ERBʱ and sterol regulatory element-bind-
ing transcription factor 1a (SREBP1a) mRNA were
determined by real-time PCR.
Fasting serum insulin was measured by chemi-
luminescent enzyme immunoassay. Serum hs-CRP
was determined by nephelometory. Serum leptin
was  determined  by  radioimmunoassay.  Serum
adiponectin was measured by an enzyme-linked
immunosorbent assay.
The homeostasis model assessment (HOMA-IR)
index was calculated with the expression: insulin
[mU/ml] × blood glucose [mg/dl]/405.
D De et te er rm mi in na at ti io on n   o of f   m mR RN NA A   e ex xp pr re es ss si io on n
Blood samples were collected in heparin tubes,
layered on a Ficoll-Paque density gradient (Sigma)
and centrifuged at 400 × g for 30 min at room tem-
perature to isolate peripheral blood mononuclear
cells. Total RNA was isolated from the peripheral
blood mononuclear cells and reverse-transcribed as
described previously [24]. Real-time quantitative
PCR was performed with cDNA that had been dilut-
ed 3 times, using TaqMan Universal Master Mix
(Applied Biosystems, Foster City, CA), and an ABI
7500  sequence  detector  (Applied  Biosystems)Arch Med Sci 6, December / 2011 935
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according to the manufacturer’s instructions. Assay-
on-Demand primers and probes were purchased
from Applied Biosystems, and 18-s rRNA was used
for sample normalization. Real-time PCR data were
analysed using a standard curve. In all cases, the
correlation coefficients for the standard curves were
> 0.90. 
S St ta at ti is st ti ic ca al l   a an na al ly ys si is s   
Results are shown as the mean ± standard error
of the mean (SEM). The significance of differences
between mean values was evaluated by Student’s
t-test for unpaired data. A p value less than 0.05
was considered significant. 
Results
S Su ub bj je ec ct t   c ch ha ar ra ac ct te er ri is st ti ic cs s   
General characteristics of all participants are
summarized in Table I. Obese subjects had signifi-
cantly higher systolic and diastolic blood pressure
compared with non-obese subjects. Serum choles-
terol (total and LDL) and triglyceride levels were also
significantly higher in obese subjects. In the obese
group HOMA-IR was significantly higher compared
to the non-obese group (4.08 and 1.22 respective-
ly). Plasma leptin level was significantly higher, and
plasma adiponectin level was significantly lower in
obese subjects compared to non-obese subjects.
The obese subjects in this study displayed common
features of obese or metabolic syndrome partici-
pants. 
E Ex xp pr re es ss si io on n   p pr ro of fi il le e   v va ar ri ia at ti io on n   i in n   p pl la as sm ma a   g gl lu uc co os se e, ,
t tr ri ig gl ly yc ce er ri id de e   a an nd d   f fr re ee e   f fa at tt ty y   a ac ci id d   l le ev ve el ls s
Figure 1 shows the circadian variation in plasma
cortisol and melatonin levels of individual subjects
in both the obese and non-obese group. Plasma
cortisol level reached its acrophase in the morning
(Figure 1 A-B). In both groups, plasma melatonin lev-
el reached its acrophase at midnight (Figure 1 C-D).
These data suggest that the subjects’ circadian
rhythms were maintained. Figure 2 demonstrates
circadian variation of plasma glucose (Figure 2 A)
and free fatty acid levels (Figure 2 B). There was no
significant difference in plasma glucose level at any
time point between the obese and non-obese
groups. The plasma free fatty acid level increased
at 09:00 and 18:00. This pattern was seen in both
the obese and non-obese groups. However, the
plasma free fatty acid levels were significantly high-
er in the obese subjects at 15:00, 18:00 and 21:00
compared to the non-obese controls.
In the non-obese group, the plasma triglyceride
level at each time-point was less than 150 mg/dl,
with few exceptions. However, in the obese group,
the serum triglyceride level was significantly high-
er. The plasma triglyceride level in the obese group
was higher than 200 mg/dl at 15:00 and 21:00, sug-
gesting postprandial hyperlipidaemia in the obese
subjects (Figure 3).
E Ex xp pr re es ss si io on n   p pr ro of fi il le e   v va ar ri ia at ti io on n   o of f   c cl lo oc ck k   g ge en ne es s   
i in n   p pe er ri ip ph he er ra al l   b bl lo oo od d   m mo on no on nu uc cl le ea ar r   c ce el ll ls s
The quantitative gene expression pattern of
BMAL1 in human peripheral blood mononuclear
cells is shown in Figure 4 A. There was a highly sig-
nificant variation seen in the expression of BMAL1
in the obese group compared to the non-obese
group. In the obese group, expression of BMAL1 was
much higher during the day. BMAL1 mRNA was
more highly expressed at 15:00 and 21:00, where-
as in non-obese subjects BMAL1 mRNA expression
displayed only a weak rhythm. 
The expression pattern of the clock gene com-
ponents Cry1, Cry2, Per1 and Per2 in peripheral
blood mononuclear cells is shown in Figure 4 B-E.
Expression of Cry1 and Cry2 was rhythmic in periph-
eral blood mononuclear cells from obese subjects
but not in those from the non-obese controls. Cry1
P Pa ar ra am me et te er r N No on n   o ob be es si it ty y    O Ob be es si it ty y   
( (B BM MI I   < 2 25 5   k kg g/ /m m2 2) ) ( (B BM MI I      ≥ 2 25 5   k kg g/ /m m2 2) )
n 10 10
Height [cm] 170.4 ±2.0 169.6 ±1.4
Weight [kg] 63.2 ±2.4  92.9 ±6.9*
WC [cm] 73.6 ±1.2  101.8 ±5.1*
BMI [kg/m2] 21.7 ±0.6  32.2 ±2.1*
Age [year] 24.1 ±1.3  29.6 ±1.9**
sBP [mmHg] 123.1 ±3.7 141.2 ±6.9**
dBP [mmHg] 71.3 ±2.8 87.0 ±4.0*
Total cholesterol  179.7 ±9.1 215.6 ±13.1**
[mg/dl]
HDL cholesterol  64.8 ±3.4 54.7 ±2.5**
[mg/dl]
LDL cholesterol  100.8 ±7.8 131.2 ±11.8**
[mg/dl]
Triglyceride [mg/dl] 70.7 ±12.8 148.6 ±16.0*
FFA [mEq/l] 0.42 ±0.05 0.40 ±0.04
IRI [µIU/ml] 5.22 ±0.51 14.0 ±2.9**
Glucose [mg/dl] 95.0 ±1.2 114.4 ±10.8
HOMA-IR 1.22 ±0.12 4.08 ±0.96**
UA [mg/dl] 5.3 ±0.4 6.3 ±0.4
hsCRP [ng/ml] 1006.6 ±373.5 2589.4 ±871.5
Leptin [ng/ml] 1.9 ±0.4 8.6 ±1.9*
Adiponectin [µg/ml] 8.1 ±0.74 5.5 ±0.7**
T Ta ab bl le e   I I. . Characteristics of the subjects
Mean ± SE, *p < 0.01, **p < 0.05936 Arch Med Sci 6, December / 2011
K. Tahira, T. Ueno, N. Fukuda, T. Aoyama, A. Tsunemi, S. Matsumoto, C. Nagura, T. Matsumoto, M. Soma, S. Shimba, Y. Matsumoto
and Cry2 expression was increased after 15:00 in
the obese group. Interestingly, Per1 mRNA expres-
sion in peripheral blood mononuclear cells did not
show the same sort of expression profile variation
as was seen with BMAL1, Cry1 or Cry2, being high-
est in the morning. The expression pattern of PER1
differed significantly between the obese group and
the non-obese controls. However, the circadian vari-
ation in expression of Per2 mRNA was almost the
same as that of BMAL1, Cry1 and Cry2.
SREBP1,  a transcription  factor  that  targets
enzymes involved in regulation of glycolysis, ener-
gy production, lipogenesis and cholesterol catabo-
lism, also displays variation of expression in periph-
eral blood mononuclear cells (Figure 4 F). However,
the pattern of SREBP1 expression did not differ sig-
nificantly  between  the  obese  and  non-obese
groups. Rev-erbʱ, a circadian clock component that
forms a negative feedback loop, showed variation
of expression in peripheral blood mononuclear cells
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from obese subjects (Figure 4 G). Expression of 
Rev-erbʱ significantly increased after 15:00 in the
obese group compared to the non-obese controls,
displaying a similar rhythm to BMAL1, Cry1, Cry2
and Per2. 
Discussion
Expression of genes encoding key components
of central and peripheral circadian oscillators was
analysed in human peripheral blood mononuclear
cells from ten obese subjects and ten non-obese
controls to investigate the effect of obesity on the
human circadian rhythm. This study is the first to
describe changes in circadian clock genes in periph-
eral blood mononuclear cells from obese subjects.
No significant rhythmical variation was found in
expression of Bmal1, Cry1, or Cry2 from peripheral
mononuclear cells of non-obese control subjects.
In contrast, Per1 in non-obese subjects was highly
expressed at 9:00, and Per2 displayed a tendency
for higher expression at 9:00. These results confirm
previous observations on the variation of expres-
sion of clock genes in human peripheral blood
mononuclear cells in non-obese subjects [23, 25-
27]. Previous studies have examined the profile of
circadian gene expression from human peripheral
blood cells in non-obese subjects. Fukuya et al.
reported the absence of circadian oscillation in
expression of BMAL1 and Per2 in human mononu-
clear cells, whereas a significant peak in expression
of Per1 was observed at the beginning of the light
cycle [25]. Kusanagi et al. recently reported the
expression profile of 10 circadian clock genes in
peripheral blood mononuclear cells. In their study,
Bmal1, Cry1 and Cry2 genes did not show rhythmi-
cal changes in expression in human peripheral
blood mononuclear cells, whereas robust expres-
sion of Per1, Per2 and Per3 genes was observed in
the morning [26]. These results suggest that Per1
and Per2 may play a role in regulation of the circa-
dian rhythm in human peripheral mononuclear cells
in non-obese subjects.
In obese subjects, Bmal1 gene expression was
significantly higher during the day compared to
non-obese controls. Bmal1 expression tended to be
higher  after  15:00,  showing  obvious  rhythmic
expression. In this period, plasma triglyceride and
glucose levels were also higher in obese subjects
compared to the non-obese controls. In mammals,
the CLOCK and BMAL1 heterodimer provides the
basic drive for circadian rhythmic transcriptional
enhancement. The heterodimer directly or indirectly
activates transcription of circadian effecter genes
[7, 28]. Because BMAL1/CLOCK is known to play an
important role in lipid homeostasis through regu-
lation of circadian activation of potential PPAR
response element controlled target genes [29],
BMAL1 upregulation during hyperlipidaemic and
hyperglycaemic periods in obese subjects is an
important phenomenon that will help to under-
stand lipid metabolism in the development of obe-
sity. The contribution of BMAL1 to the regulation of
adipogenesis and adipocyte function has been sug-
gested by many studies. BMAL1 is highly expressed
during adipogenesis [21], and Bmal1 deficient mice
lack diurnal variation in triglyceride levels [30]. More
importantly, mice lacking the circadian regulatory
system are obese and develop a metabolic syn-
drome [31]. Growing evidence suggests a role for
BMAL1 in obesity and its related symptoms.
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Studies that have compared two or more tissues
have suggested that, although the genetic compo-
nents of the circadian pacemaker are similar across
tissues, individual genes exhibit rhythmic expres-
sion in a tissue-specific manner. Panda et al. found
that only 28 genes (of more than 7000 known
genes) were rhythmically expressed in both the
suprachiasmatic nucleus and the liver [29]. Our cur-
rent study found an altered expression of circadian
clock genes in peripheral blood mononuclear cells.
Peripheral blood mononuclear cells are a source of
adipose  tissue  macrophages.  In  humans  and
rodents, adipose tissue macrophages accumulate
in adipose tissue with increasing body weight and
their quantity correlates with a measure of insulin
resistance [32-34]. Lumeng et al. reported that 
diet-induced obesity leads to a shift in the activa-
tion state of adipose tissue macrophages, from
a non-inflammatory state that in lean animals may
protect adipocytes against inflammation, to a proin-
flammatory state that contributes to insulin resist-
ance [35]. From these observations, it is possible
that there is a relationship between peripheral blood
mononuclear cell clock gene variation and adipose
tissue gene expression.
CLOCK/BMAL1  drives  translocation  through 
E-boxes located within the promoter of various tar-
get genes including Per1, Per2, Cry1 and Cry2. When
Per and Cry are translocated, they heterodimerize,
translocate to the nucleus, and repress transcrip-
tional activity at E-boxes. Interestingly, circadian
variation of Per1 in human peripheral mononuclear
cells in obese subjects did not appear to be linked
with the circadian variation of other clock genes.
This result could indicate that Per1 plays some
unknown but unique role in the circadian regula-
tion  of  gene  expression  in  human  peripheral
mononuclear cells. 
SREBP1 and REV-ERBʱ were also found to be
upregulated, and their expression also oscillated 
in obese subjects. The E-box is known to exist in
the promoter region of several genes that are
involved in synthesis of fatty acids such as SREBP1
and REV-ERBʱ. Bmal1 may play a role in the syn-
thesis of fatty acids by interacting with these genes.
In conclusion, the expression patterns of circa-
dian rhythm-related genes in peripheral blood
mononuclear cells showed marked variation in
expression profile, suggesting their usefulness in
human circadian rhythm research. Differences exist-
ed in the expression profile variation of these genes
between the obese and non-obese groups, sug-
gesting an association between the onset/aggra-
vation of obesity, and circadian rhythm-related gene
expression. This work reveals the variability of clock
gene expression profiles from peripheral mononu-
clear cells from both obese and non-obese subjects,
with evidence for two distinct chronotypes, and
suggests a contribution of these chronotypes in fat
accumulation in humans. 
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